Below are the most recent publications written about "Urinary Bladder" by people in Profiles.
-
Bogie AL, Sparkman A, Anderson M, Crittenden-Byers C, Barron M. Is There a Difference in the Contamination Rates of Urine Samples Obtained by Bladder Catheterization and Clean-Catch Collection in Preschool Children? Pediatr Emerg Care. 2021 Dec 01; 37(12):e788-e790.
-
Towner RA, Greenwood-Van Meerveld B, Mohammadi E, Saunders D, Smith N, Sant GR, Shain HC, Jozefiak TH, Hurst RE. SuperGAG biopolymers for treatment of excessive bladder permeability. Pharmacol Res Perspect. 2021 02; 9(1):e00709.
-
Sen A, Kaul A, Kaul R. Estrogen receptors in human bladder cells regulate innate cytokine responses to differentially modulate uropathogenic E. coli colonization. Immunobiology. 2021 01; 226(1):152020.
-
Lade C, Lewis S, Venincasa K, Harmon A, Choi P, Lee B, Raines A. Feasibility of robotic-assisted minimally invasive inguinal hernia repair in patients with urologic considerations including artificial urinary sphincters and bladder herniation. J Robot Surg. 2021 Oct; 15(5):695-699.
-
Smith N, Saunders D, Lerner M, Zalles M, Mamedova N, Cheong D, Mohammadi E, Yuan T, Luo Y, Hurst RE, Greenwood-Van Meerveld B, Towner RA. In vivo and ex vivo assessment of bladder hyper-permeability and using molecular targeted magnetic resonance imaging to detect claudin-2 in a mouse model for interstitial cystitis. PLoS One. 2020; 15(10):e0239282.
-
Rodriguez J, Patel S. Editorial Comment. J Urol. 2020 11; 204(5):988.
-
Wu DH, Chen Z, North JC, Biswas M, Vo J, Suri JS. Machine learning paradigm for dynamic contrast-enhanced MRI evaluation of expanding bladder. Front Biosci (Landmark Ed). 2020 06 01; 25(9):1746-1764.
-
Furr J, Gelman J. Endoscopic Management of Urethral Stricture Disease and Bladder Neck Contractures. J Endourol. 2020 05; 34(S1):S7-S12.
-
Joseph DB, Baum MA, Tanaka ST, Frimberger DC, Misseri R, Khavari R, Baillie S, Yerkes EB, Wood H. Urologic guidelines for the care and management of people with spina bifida. J Pediatr Rehabil Med. 2020; 13(4):479-489.
-
Assia Batzir N, Kishor Bhagwat P, Larson A, Coban Akdemir Z, Baglaj M, Bofferding L, Bosanko KB, Bouassida S, Callewaert B, Cannon A, Enchautegui Colon Y, Garnica AD, Harr MH, Heck S, Hurst ACE, Jhangiani SN, Isidor B, Littlejohn RO, Liu P, Magoulas P, Mar Fan H, Marom R, McLean S, Nezarati MM, Nugent KM, Petersen MB, Rocha ML, Roeder E, Smigiel R, Tully I, Weisfeld-Adams J, Wells KO, Posey JE, Lupski JR, Beaudet AL, Wangler MF. Recurrent arginine substitutions in the ACTG2 gene are the primary driver of disease burden and severity in visceral myopathy. Hum Mutat. 2020 03; 41(3):641-654.